The corporate practice at Trowers & Hamlins LLP has a particular focus on private equity-backed transactions in the healthcare, pharmaceuticals, and real estate sectors. The group has key strength in cross-border transactions. Private equity specialist Tim Nye leads the team and has extensive experience assisting clients on restructuring, refinancing, and sales, as well as acquisitions, disposals, and investments. Nye is also adept at handling complex transactions involving cross-border jurisdictions. Health, social care, and life sciences sector authority Alison Chivers is another notable name in the group for her aptitude in M&A deals, investments, disposals, restructurings, and joint ventures. Chivers is frequently instructed by institutional investors, private equity houses, corporates, and management teams.
Legal 500 redaktioneller Kommentar
- Profil
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
‘My go-to practice for all things legal - a great team that I enjoy working with.’
‘The team understand the client's business. They worked closely with us on the sale of the business and kept us informed throughout. Nothing was too much trouble when we needed their support. The team is also diverse, and we all worked together very well.’
‘Trowers have specialist expertise in the recruitment sector, which adds value to clients doing deals in that market.’
'Partner led approach, which leads to never feeling pushed to a team member with less experience, but still getting the benefit of a wider team with varied specialisms as required.'
Kernmandanten
- The shareholders of Oakley Advisory Limited
- CNX Therapeutics Limited
- The shareholders of Profile Security Group Limited
- Willow AssetCo Limited
- Rosemont Pharmaceuticals Limited
- The shareholders of Banks Renewables (HL) Holdings Ltd
- The shareholders of UK Container Maintenance Limited
- Egbert Taylor Holdings Limited
- The Management Team of Cakesmiths
- AME International (UK) Limited
Highlight-Mandate
Advised CNX Therapeutics Limited on its asset acquisition of 4 injectable cancer medications from Clinigen Limited and Clinigen Healthcare Limited
Advised the selling shareholders on the sale of the entire issued share capital of Profile Security Group Ltd and its subsidiaries to OCS Security Limited.
Advised Rosemont Pharmaceuticals Limited on its acquisition of the entire issued share capital of Lucis Holdings Limited and 60% of the issued share capital of Lucis Pharma Ltd.
Anwält*innen
Führende Partner*innen
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Praxisleitung
Tim Nye
Weitere Kernanwält*innen
Alison Chivers